30904-99-5 Usage
Description
1-(4-chlorophenyl)-3-ethylthiourea, commonly known as propham, is a chemical compound that serves as an essential tool in the agricultural industry. It is characterized by its ability to inhibit cell division and growth in plants, which makes it an effective herbicide and sprout inhibitor.
Uses
Used in Agriculture:
1-(4-chlorophenyl)-3-ethylthiourea is used as an herbicide for controlling the growth of weeds and unwanted plants in areas where crops are being cultivated. Its application helps to reduce competition for resources, ensuring the healthy growth and development of desired plants.
1-(4-chlorophenyl)-3-ethylthiourea is also used as a sprout inhibitor for potatoes and other root vegetables during storage. By preventing sprouting, it helps to maintain the quality and freshness of these vegetables, reducing spoilage and waste.
Check Digit Verification of cas no
The CAS Registry Mumber 30904-99-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,9,0 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 30904-99:
(7*3)+(6*0)+(5*9)+(4*0)+(3*4)+(2*9)+(1*9)=105
105 % 10 = 5
So 30904-99-5 is a valid CAS Registry Number.
30904-99-5Relevant articles and documents
Synthesis of thiazolidines via regioselective addition of unsymmetric thioureas to maleic acid derivatives
Pankova, Alena S.,Samartsev, Mikhail A.,Shulgin, Igor A.,Golubev, Pavel R.,Avdontceva, Margarita S.,Kuznetsov, Mikhail A.
, p. 51780 - 51786 (2014/12/10)
A wide range of unsymmetric thioureas has been studied in reaction with N-arylmaleimides and maleic anhydride. The regioselectivity of the addition depends not only on steric factors but on both solvent polarity and type of maleic acid derivative (imide o
COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
-
Page/Page column 41, (2008/06/13)
Compounds of formula (I), and salts and solvates thereof for use as a medicament are provided: (I) wherein R1, R2, R4, R10, X and Z are defined in the specification. Processes for preparation, pharmaceutical com
